Metropolitan Life Insurance Company (MetLife)’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,615
Closed -$89.2K 1865
2024
Q1
$89.2K Sell
2,615
-261
-9% -$8.9K ﹤0.01% 1107
2023
Q4
$83.2K Hold
2,876
﹤0.01% 1183
2023
Q3
$79.3K Buy
2,876
+221
+8% +$6.09K ﹤0.01% 1141
2023
Q2
$79.8K Sell
2,655
-163
-6% -$4.9K ﹤0.01% 1142
2023
Q1
$102K Sell
2,818
-249
-8% -$9.02K 0.01% 984
2022
Q4
$109K Buy
3,067
+149
+5% +$5.32K ﹤0.01% 1002
2022
Q3
$98.8K Hold
2,918
﹤0.01% 1025
2022
Q2
$84.4K Hold
2,918
﹤0.01% 1166
2022
Q1
$94.3K Sell
2,918
-10,341
-78% -$334K ﹤0.01% 1231
2021
Q4
$387K Hold
13,259
0.01% 1592
2021
Q3
$354K Sell
13,259
-2,553
-16% -$68.1K 0.01% 1666
2021
Q2
$487K Buy
15,812
+585
+4% +$18K 0.01% 1542
2021
Q1
$399K Sell
15,227
-677
-4% -$17.7K 0.01% 1556
2020
Q4
$400K Hold
15,904
0.01% 1503
2020
Q3
$331K Hold
15,904
0.01% 1476
2020
Q2
$378K Hold
15,904
0.01% 1406
2020
Q1
$286K Hold
15,904
0.01% 1377
2019
Q4
$377K Hold
15,904
0.01% 1507
2019
Q3
$437K Hold
15,904
0.01% 1382
2019
Q2
$526K Hold
15,904
0.01% 1270
2019
Q1
$557K Hold
15,904
0.01% 1231
2018
Q4
$528K Hold
15,904
0.01% 1162
2018
Q3
$801K Hold
15,904
0.01% 1057
2018
Q2
$952K Buy
15,904
+187
+1% +$11.2K 0.02% 946
2018
Q1
$720K Hold
15,717
0.01% 1062
2017
Q4
$626K Sell
15,717
-15,581
-50% -$621K 0.01% 1132
2017
Q3
$1.25M Sell
31,298
-2,388
-7% -$95.5K 0.01% 1125
2017
Q2
$1.45M Hold
33,686
0.01% 1066
2017
Q1
$1.05M Sell
33,686
-1,117
-3% -$35K 0.01% 1206
2016
Q4
$879K Hold
34,803
0.01% 1363
2016
Q3
$861K Hold
34,803
0.01% 1366
2016
Q2
$709K Buy
34,803
+4,670
+15% +$95.1K 0.01% 1470
2016
Q1
$460K Buy
30,133
+7,162
+31% +$109K ﹤0.01% 1626
2015
Q4
$309K Hold
22,971
﹤0.01% 1940
2015
Q3
$322K Sell
22,971
-2,303
-9% -$32.3K ﹤0.01% 1935
2015
Q2
$429K Buy
25,274
+1,554
+7% +$26.4K ﹤0.01% 1849
2015
Q1
$287K Hold
23,720
﹤0.01% 1868
2014
Q4
$197K Hold
23,720
﹤0.01% 2422
2014
Q3
$206K Hold
23,720
﹤0.01% 2346
2014
Q2
$260K Buy
+23,720
New +$260K ﹤0.01% 2320